J2 Capital Management Inc Makes New $353,000 Investment in DocuSign, Inc. (NASDAQ:DOCU)

J2 Capital Management Inc acquired a new stake in DocuSign, Inc. (NASDAQ:DOCU - Free Report) in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 4,335 shares of the company's stock, valued at approximately $353,000.

A number of other large investors have also made changes to their positions in DOCU. Kestra Investment Management LLC acquired a new stake in DocuSign in the 4th quarter valued at about $30,000. First Horizon Advisors Inc. boosted its holdings in shares of DocuSign by 102.6% in the 4th quarter. First Horizon Advisors Inc. now owns 397 shares of the company's stock valued at $36,000 after purchasing an additional 201 shares in the last quarter. Wood Tarver Financial Group LLC acquired a new stake in shares of DocuSign during the 4th quarter valued at $37,000. MassMutual Private Wealth & Trust FSB boosted its holdings in shares of DocuSign by 153.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 453 shares of the company's stock valued at $37,000 after acquiring an additional 274 shares in the last quarter. Finally, McIlrath & Eck LLC boosted its holdings in shares of DocuSign by 476.0% during the 4th quarter. McIlrath & Eck LLC now owns 432 shares of the company's stock valued at $39,000 after acquiring an additional 357 shares in the last quarter. Institutional investors own 77.64% of the company's stock.

Insider Activity

In other news, insider James P. Shaughnessy sold 7,500 shares of DocuSign stock in a transaction dated Tuesday, April 1st. The shares were sold at an average price of $81.31, for a total value of $609,825.00. Following the sale, the insider now owns 45,875 shares of the company's stock, valued at $3,730,096.25. The trade was a 14.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Teresa Briggs sold 534 shares of the business's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $87.41, for a total transaction of $46,676.94. Following the sale, the director now directly owns 8,270 shares in the company, valued at approximately $722,880.70. This represents a 6.07% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 47,851 shares of company stock valued at $3,912,239 in the last 90 days. Company insiders own 1.01% of the company's stock.

DocuSign Trading Up 0.7%

Shares of NASDAQ:DOCU traded up $0.59 on Monday, hitting $89.20. 2,055,752 shares of the company were exchanged, compared to its average volume of 2,778,416. DocuSign, Inc. has a 1-year low of $48.70 and a 1-year high of $107.86. The stock's 50 day moving average price is $81.62 and its 200 day moving average price is $85.99. The firm has a market capitalization of $18.06 billion, a P/E ratio of 18.39, a price-to-earnings-growth ratio of 6.94 and a beta of 1.21.

DocuSign (NASDAQ:DOCU - Get Free Report) last issued its quarterly earnings data on Thursday, March 13th. The company reported $0.86 earnings per share for the quarter, topping analysts' consensus estimates of $0.84 by $0.02. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The business had revenue of $776.25 million during the quarter, compared to the consensus estimate of $760.94 million. During the same quarter in the prior year, the firm posted $0.76 earnings per share. The company's revenue was up 9.0% compared to the same quarter last year. On average, equities analysts predict that DocuSign, Inc. will post 1.17 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts have commented on DOCU shares. Needham & Company LLC reaffirmed a "hold" rating on shares of DocuSign in a report on Thursday, April 17th. Morgan Stanley decreased their price objective on DocuSign from $97.00 to $92.00 and set an "equal weight" rating for the company in a report on Wednesday, April 16th. Wells Fargo & Company cut their target price on DocuSign from $73.00 to $65.00 and set an "underweight" rating on the stock in a research note on Tuesday, April 22nd. Citigroup upped their price objective on DocuSign from $113.00 to $115.00 and gave the company a "buy" rating in a research note on Friday, March 14th. Finally, UBS Group dropped their price objective on DocuSign from $90.00 to $85.00 and set a "neutral" rating on the stock in a research note on Thursday, April 17th. One analyst has rated the stock with a sell rating, eleven have given a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat, DocuSign presently has an average rating of "Hold" and a consensus target price of $92.46.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.